Ruthenium(II)-arene complexes with functionalized pyridines: Synthesis, characterization and cytotoxic activity

European Journal of Medicinal Chemistry

Volumn 45, Issue 3, 2010, Pages 1051-1058

  Grgurić Šipka, Sanja ^a   Ivanović, Ivanka ^a   Rakić, Gordana ^a   Todorović, Nina ^b   Gligorijević, Nevenka ^c   Radulović, Siniša ^c   Arion, Vladimir B ^d   Keppler, Bernhard K ^d   Tešić, Živoslav Lj ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cytotoxicity; Pyridine derivatives; Ruthenium(II) arene

Indexed keywords

9 METHYLADENINE; ANTINEOPLASTIC AGENT; DICARBOXYLIC ACID DERIVATIVE; DIPICOLINIC ACID; ISONICOTINIC ACID; NICOTINIC ACID; PYRIDINE DERIVATIVE; QUINOLINIC ACID; RUTHENIUM COMPLEX;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CHEMICAL REACTION; COMPLEX FORMATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; FINITE ELEMENT ANALYSIS; GEOMETRY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NUCLEAR OVERHAUSER EFFECT; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR CELL LINE; X RAY CRYSTALLOGRAPHY;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CRYSTALLOGRAPHY, X-RAY; DRUG SCREENING ASSAYS, ANTITUMOR; HELA CELLS; HUMANS; HYDROGEN BONDING; INHIBITORY CONCENTRATION 50; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NEOPLASMS; ORGANOMETALLIC COMPOUNDS; RUTHENIUM;

EID: 75949128866     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.11.055     Document Type: Article

References (44)

1. Yan Y.K., Melchart M., Habtemariam A., and Sadler P.J. Chem. Commun. (2005) 4764-4776
2. Melchart M., and Sadler P.J. In: Jaouen G. (Ed). Bioorganometallics: Biomolecules, Labeling, Medicine (2006), Wiley-VCH, Weinheim 39-62
3. Schmitt F., Govindaswamy P., Süss-Fink G., Ang W.H., Dyson P.J., Juillerat-Jeanneret L., and Therrien B. J. Med. Chem. 51 (2008) 1811-1816
4. Schmid W.F., John R.O., Arion V.B., Jakupec M.A., and Keppler B.K. Organometallics 26 (2007) 6643-6652
5. Vock C.A., Scolaro C., Phillips A.D., Scopelliti R., Sava G., and Dyson P.J. J. Med. Chem. 49 (2006) 5552-5561
6. Vock C.A., Ang W.H., Scolaro C., Phillips A.D., Lagopoulos L., Juillerat-Jeanneret L., Sava G., Scopelliti R., and Dyson P.J. J. Med. Chem. 50 (2007) 2166-2175
7. Dale L.D., Tocher J.H., Dyson T.M., Edwards D.I., and Tocher D.A. Anti-Cancer Drug Des. 7 (1992) 3-14
8. Aird R.E., Cummings J., Ritchie A.A., Muir M., Morris R.E., Chen H., Sadler P.J., and Jodrell D.I. Br. J. Cancer 86 (2002) 1652-1657
9. Morris R.E., Aird R.E., Murdoch P.D.S., Chen H., Cummings J., Hughes N.D., Parsons S., Parkin A., Boyd G., Jodrell D.I., and Sadler P.J. J. Med. Chem. 44 (2001) 3616-3621
10. Habtemariam A., Melchart M., Fernández R., Parsons S., Oswald I.D.H., Parkin A., Fabbiani F.P.A., Davidson J.E., Dawson A., Aird R.E., Jodrell D.I., and Sadler P.A. J. Med. Chem. 49 (2006) 6858-6868
11. Melchart M., Habtemariam A., Parsons S., Moggach S.A., and Sadler P.J. Inorg. Chim. Acta 359 (2006) 3020-3028
12. Ang W.H., and Dyson P.J. Eur. J. Inorg. Chem. (2006) 4003-4018
13. Scolaro C., Bergamo A., Brescacin L., Delfino R., Cocchietto M., Laurenczy G., Geldcbach T.J., Sava G., and Dyson P.J. J. Med. Chem. 48 (2005) 4161-4171
14. Allardyce C.S., Dorcier A., Scolaro C., and Dyson P.J. Appl. Organomet. Chem. 19 (2005) 1-10
15. Dougan S.J., Melchart M., Habtemariam A., Parsons S., and Sadler P.J. Inorg. Chem. 45 (2006) 10882-10894
16. Dutta B., Scolaro C., Scopelliti R., Dyson P.J., and Severin K. Organometallics 27 (2008) 1355-1357
17. Vock C.A., Renfrew A.K., Scopelliti R., Juillerat-Jeanneret L., and Dyson P.J. Eur. J. Inorg. Chem. (2008) 1661-1671
18. Galeano A., Berger M.R., and Keppler B.K. Arzneim-Forsch/Drug Res. 42 (1992) 821-824
19. Sava G., Gagliardi R., Bergamo A., Alessio E., and Mestroni G. Anticancer Res. 19 (1999) 969-972
20. Kapitza S., Pongratz M., Jakupec M.A., Heffeter P., Berger W., Lackinger L., Keppler B.K., and Marian B. J. Cancer Res. Clin. Oncol. 131 (2005) 101-110
21. Rademaker-Lakhai J.M., van den Bongard D., Pluim D., Beijnen J.H., and Schellens J.H.M. Clin. Cancer Res. 10 (2004) 3717-3727
22. Dyson P.J., and Sava G. Dalton Trans. (2006) 1929-1933
23. Dette C., Waertzig H., and Uhl H. Pharmazie 48 (1993) 276-280
24. Tochikubo K., Hachisuka Y., and Murachi T. Jpn. J. Microbiol. 12 (1968) 435-440
25. Hachisuka Y., Tochikubo K., Yokoi Y., and Murachi T. J. Biol. Chem. 61 (1967) 659-661
26. Griggs D.L., Heden P., Temple Smith K.E., and Rademacher W. Phytochemistry 30 (1991) 2513-2517
27. Martin B.L. Arch. Biochem. Biophys. 345 (1997) 332-338
28. Laine P., Gourdon A., and Launay J.P. Inorg. Chem. 34 (1995) 5129-5137
29. Mauk A.G., Coyle C.L., Bardingnon E., and Gray H.B. J. Am. Chem. Soc. 101 (1979) 5054-5056
30. Groves J.T., and Kady I.O. Inorg. Chem. 32 (1993) 3868-3972
31. Farrell N., and Kelland L.R. In: Farrell N.P. (Ed). Platinum-Based Drugs in Cancer Therapy (2000), Humana Press, Totowa 321-338
32. Baruah A.M., Karmakar A., and Baruah J.B. Polyhedron 26 (2007) 4518-4524
33. Sengupta P., Ghosh S., and Mak T.C.W. Polyhedron 20 (2001) 975-980
34. Kostova I. Curr. Med. Chem. 13 (2006) 1085-1107
35. Gianferrara T., Bratsos I., and Alessio E. Dalton Trans. (2009) 7588-7598
36. Bergamo A., Messori L., Paccioli F., Cocchietto M., and Sava G. Invest. New Drugs 21 (2003) 401-411
37. Levina A., Mitra A., and Lay P.A. Metallomics 1 (2009) 458-470
38. Jensen S.B., Rodger S.J., and Spicer M.D. J. Organomet. Chem. 556 (1998) 151-158
39. SAINT-Plus (Version 7.06a) and APEX2 (2004), Bruker-Nonius AXS Inc., Madison, Wisconsin, USA
40. Sheldrick G.M. SHELXS-97, Program for Crystal Structure Solution (1997), University Göttingen, Göttingen, Germany
41. Sheldrick G.M. SHELXS-97, Program for Crystal Structure Refinement (1997), University Göttingen, Göttingen, Germany
42. Johnson G.K. Report ORNL-5138 (1976), Oak Ridge National Laboratory, Oak Ridge, Tennessee
43. In: Wilson A.J.C. (Ed). International Tables for X-ray Crystallography vol. C (1992), Kluwer Academic Press, Dodrecht, The Netherlands Tables 4.2.6.8 and 6.1.1.4
44. Supino R. In: O'Hare S., and Atterwill C.K. (Eds). Methods in Molecular Biology, in Vitro Toxicity Testing Protocols (1995), Humana Press, New Jersey 137-149